315 related articles for article (PubMed ID: 28189817)
1. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice.
Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS
Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of a novel antithrombotic compound, S002-333 and enantiomers: metabolic stability, species comparison and in vitro-in vivo extrapolation.
Saxena A; Valicherla GR; Jain GK; Bhatta RS; Saxena AK; Gayen JR
Biopharm Drug Dispos; 2016 May; 37(4):185-99. PubMed ID: 26477787
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits.
Saxena A; Valicherla GR; Joshi P; Saxena R; Cheruvu SH; Bhunia SS; Jain GK; Siddiqui HH; Saxena AK; Gayen JR
Xenobiotica; 2015; 45(11):1016-23. PubMed ID: 26084373
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of a novel antithrombotic compound, S002-333, and its enantiomers: quantitative cytochrome P450 phenotyping, metabolic profiling and enzyme kinetic studies.
Saxena A; Jain GK; Siddiqui HH; Bhunia SS; Saxena AK; Gayen JR
Xenobiotica; 2014 Apr; 44(4):295-308. PubMed ID: 23992115
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC-MS/MS.
Bhateria M; Ramakrishna R; Puttrevu SK; Yerrabelli S; Saxena AK; Bhatta RS
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1031():154-162. PubMed ID: 27491065
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective pharmacokinetics and metabolism of the enantiomers of cyclophosphamide. Preliminary results in humans and rabbits.
Holm KA; Kindberg CG; Stobaugh JF; Slavik M; Riley CM
Biochem Pharmacol; 1990 Apr; 39(8):1375-84. PubMed ID: 2322319
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
Horikiri Y; Suzuki T; Mizobe M
J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
[TBL] [Abstract][Full Text] [Related]
9. Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate.
Hamdy DA; Brocks DR
Chirality; 2009 Jul; 21(7):704-12. PubMed ID: 18988259
[TBL] [Abstract][Full Text] [Related]
10. The truth about the lower plasma concentration of the (-)-isomer after racemic doxazosin administration in rats: Stereoselective inhibition of the (-)-isomer by the (+)-isomer at CYP3A.
Kong D; Li Q; Zhang P; Zhang W; Zhen Y; Ren L
Eur J Pharm Sci; 2015 Sep; 77():238-45. PubMed ID: 26116989
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding, and in vitro metabolism.
Brocks DR; Jamali F
J Pharm Sci; 1991 Nov; 80(11):1058-61. PubMed ID: 1839997
[TBL] [Abstract][Full Text] [Related]
13. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
Hussein Z; Mulford DJ; Bopp BA; Granneman GR
Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective excretion and first-pass metabolism of clausenamide enantiomers.
Zhu CJ; Wang LJ; Hua F; Yu XM; Zhang JT
Eur J Pharm Sci; 2013 Jul; 49(4):761-6. PubMed ID: 23684935
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective disposition and protein binding of [(5,6-dichloro-9a-propyl-3-oxo-2,3,9,9a-tetrahydro-1-H-fluoren-7 -yl)-oxy] acetic acid, a new cerebral antiedemic agent, in rats.
Lin JH; Hsieh JY
Drug Metab Dispos; 1988; 16(4):540-5. PubMed ID: 2903020
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
Marier JF; Pichette V; du Souich P
Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective disposition of pranoprofen, a nonsteroidal antiinflammatory drug, in rabbits.
Nomura T; Imai T; Otagiri M
Biol Pharm Bull; 1993 Mar; 16(3):298-303. PubMed ID: 8364476
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H
Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate.
Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G
Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
